Related Experiment Video
Updated: Jul 6, 2026

Chronic Stress Shifts Effort-Related Choice Behavior in a Y-Maze Barrier Task in Mice
Published on: August 13, 2020
Inhaled corticosteroids do not affect behaviour
T W de Vries1, E N van Roon, E J Duiverman
1Department of Pediatrics, Medical Centre Leeuwarden, Leeuwarden, The Netherlands. tjalling.de.vries@znb.nl
Insights
Children with asthma using inhaled corticosteroids (ICS) show more behavioral issues than healthy children. However, these differences are not significant when compared to children seeking care for other conditions, suggesting specialist care may influence behavior.
Area of Science:
- Pediatric Psychology
- Respiratory Medicine
Background:
- Asthma affects numerous children globally.
- Inhaled corticosteroids (ICS) are a primary treatment for pediatric asthma.
- Concerns exist regarding potential behavioral side effects of ICS.
Purpose of the Study:
- To investigate if children with asthma on ICS exhibit increased behavioral problems.
- To compare behavioral issues in children on ICS with healthy controls and children receiving care for other conditions.
Main Methods:
- A comparative study involving three groups: asthmatic children on ICS, children attending an ENT clinic, and healthy controls.
- Utilized questionnaires including the Child Behavior Checklist (CBCL) and ADHD rating scales.
- Collected data on health, medication, demographics, and behavior.
Main Results:
- Asthmatic children on ICS had significantly higher total CBCL and mean ADHD scores compared to healthy controls.
- No significant differences in behavioral scores were found between children on ICS and those attending the ENT clinic.
- Specific differences were noted in CBCL-axes between the ICS group and healthy controls, but not the ENT group.
Conclusions:
- Children with asthma on ICS demonstrate distinct behavioral patterns compared to healthy children.
- Behavioral differences may be linked to individual susceptibility or the impact of specialist care rather than ICS directly.
- Further research is needed to elucidate the relationship between asthma, ICS treatment, and behavioral outcomes.
Aim:
To determine whether children with asthma and on inhaled corticosteroids have more behavioural problems, such as aggressiveness and hyperactivity, as compared with healthy controls and with children under medical care because of other disorders.
Methods:
Questionnaires were given to three groups of children: a group of asthmatic children with inhaled corticosteroids (ICS), a group of children attending the ear, nose and throat (ENT) outpatient clinic and the healthy controls. Included were questions about health, medication use, demographical data and about behaviour, including the child behaviour check list (CBCL) and questions about attention deficit hyperactivity disorder (ADHD).
Results:
Forty asthmatic children on ICS, 50 children visiting the ENT outpatient clinic and 183 healthy controls were studied. The total CBCL and mean ADHD scores of the children on ICS were 28.1 and 9.1, which were both significantly higher than the scores of the healthy controls (20.4 and 7.1), but not when compared with the ENT outpatient group (26.2 and 8.6). Further analysis revealed statistically significant differences between the ICS group and healthy controls in CBCL-axes. There were, however, no differences between the ENT group and the ICS on one side and the healthy controls on the other.
Conclusion:
There is a difference in behaviour between healthy children and asthmatic children on ICS, but not when compared with children visiting the ENT department. Although hyperactivity, aggressiveness and anxiety might occur in children on ICS, this is probably caused by individual susceptibility. Being under specialist care can possibly explain behavioural differences between children on ICS and healthy controls.
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inhaled Medications
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...